Physician
Marta Markman MD & Assoc PA
Marta Markman MD & Assoc PA was paid $2.55M by Medicaid between Jan 2018 and Dec 2024, across 61 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 20% of everything it billed.
33Billing provider infoMARTA MARKMAN MD & ASSOC PA
PASADENA, MD 21122
PASADENA, MD 21122
33aNPI1275567471assigned 07/11/2006
33bProvider typePediatrics Physician
28Total paid$2.55M
24GClaims56,885
24DCodes billed61
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Pediatrics Physician providers in Maryland
Rank by total paid#43 of 306
Median peer was paid$206K
This provider vs. median12×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 314 | $8K | |
| 2019 | 310 | $8K | |
| 2020 | 10,576 | $471K | |
| 2021 | 12,346 | $541K | |
| 2022 | 11,014 | $504K | |
| 2023 | 12,221 | $547K | |
| 2024incomplete | 10,104 | $474K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 20% | 4,458 | 3,915 | $500K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 12% | 3,121 | 2,793 | $301K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 12% | 3,670 | 3,311 | $297K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 12% | 2,810 | 2,702 | $297K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 11% | 2,702 | 2,602 | $286K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 10% | 2,376 | 2,295 | $266K |
| 90686 | 2.8% | 3,144 | 2,995 | $71K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 1.7% | 2,427 | 2,351 | $44K |
| 90670 | 1.5% | 1,665 | 1,598 | $37K | |
| 96127 | 1.3% | 7,582 | 6,289 | $33K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 1.1% | 701 | 615 | $28K |
| 90680 | 1.1% | 1,244 | 1,157 | $27K |
49 more codes
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 1.0% | 237 | $26K |
| 90633 | <1% | 1,078 | $24K | |
| 90651 | <1% | 996 | $23K | |
| D1206 | Topical application of fluoride varnish | <1% | 917 | $23K |
| 90698 | <1% | 977 | $22K | |
| 90710 | <1% | 971 | $22K | |
| 90697 | <1% | 904 | $19K | |
| 99381 | <1% | 169 | $17K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 1,538 | $17K |
| 90744 | <1% | 575 | $12K | |
| 90734 | <1% | 515 | $12K | |
| 90620 | <1% | 494 | $11K | |
| W7000 | <1% | 2,214 | $11K | |
| 90677 | <1% | 478 | $10K | |
| 0001A | <1% | 274 | $10K | |
| 0002A | <1% | 252 | $10K | |
| 90619 | <1% | 462 | $9K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 903 | $9K |
| 0071A | <1% | 221 | $8K | |
| 90715 | <1% | 364 | $8K | |
| 0072A | <1% | 192 | $7K | |
| 87400 | <1% | 920 | $7K | |
| 90696 | <1% | 264 | $6K | |
| 83655 | <1% | 566 | $5K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 114 | $5K |
| 96161 | <1% | 1,727 | $5K | |
| 0004A | <1% | 91 | $3K | |
| 90656 | <1% | 175 | $3K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 274 | $3K |
| 92081 | <1% | 137 | $3K | |
| 90661 | <1% | 151 | $2K | |
| 92551 | <1% | 253 | $2K | |
| 0124A | <1% | 51 | $2K | |
| 99383 | <1% | 17 | $2K | |
| 0054A | <1% | 36 | $1K | |
| 90648 | <1% | 47 | $1K | |
| 87420 | <1% | 108 | $938.24 | |
| 85018 | <1% | 547 | $788.49 | |
| 87428 | <1% | 20 | $736.41 | |
| 90700 | <1% | 26 | $582.00 | |
| 0081A | <1% | 14 | $520.00 | |
| 0074A | <1% | 12 | $440.00 | |
| 87807 | <1% | 53 | $428.16 | |
| 81003 | <1% | 306 | $135.24 | |
| 94664 | <1% | 20 | $126.00 | |
| 94761 | <1% | 31 | $104.08 | |
| 36416 | <1% | 67 | $11.50 | |
| 99000 | 0% | 202 | $0.00 | |
| INVCD | 0% | 25 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMARKMAN, MARTA (PRESIDENT)